Drugs / Snake (Micrurus) North American immune F(ab')2 Equine
Snake (Micrurus) North American immune F(ab')2 Equine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01337245 | May 2012 → Nov 2016 | snakebite envenomation | University of Arizona | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Snake (Micrurus) North American immune F(ab')2 Equine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01337245 ↗ |
| Modality | Protein / enzyme biologic | “new F(ab')2 antivenom” NCT01337245 ↗ |
| Route | Intravenous | “administered intravenously” NCT01337245 ↗ |